Table 2. Effects of intervention on control of hypertension (primary outcome) and prescription of antihypertensive medication (secondary outcome) in people with hypertension: complete case analysis.
Outcome | Number of participants | Change from baseline to follow-up* | P value | Adjusted odds ratio (95% CI)† | P value | ||
---|---|---|---|---|---|---|---|
Intervention | UC‡ | Intervention | UC | ||||
Overall | |||||||
Control of hypertension | 459 | 1,011 | 93 (20.3) | 96 (9.5) | <0.001 |
|
0.001 |
Prescribed antihypertensive medication | 459 | 1,012 | 57 (12.4) | 100 (9.9) | 0.14 | 1.2 (0.8–1.9) | 0.34 |
Women | |||||||
Control of hypertension | 280 | 596 | 52 (18.6) | 49 (8.2) | <0.001 | 1.6 (1.1–2.2) | 0.01 |
Prescribed antihypertensive medication | 280 | 597 | 38 (13.6) | 45 (7.5) | 0.004 | 1.5 (0.9–2.2) | 0.09 |
Men | |||||||
Control of hypertension | 178 | 411 | 41 (23.0) | 48 (11.7) | <0.001 | 1.6 (1.1–2.5) | 0.02 |
Prescribed antihypertensive medication | 178 | 411 | 19 (10.7) | 54 (13.1) | 0.40 | 0.9 (0.5–1.7) | 0.85 |
There are 4 missing observations for sex in the UC group and 1 in the intervention group.
*Change in control of hypertension was obtained by subtracting the number of people with control of hypertension at baseline from the number with control at follow-up. The same approach was applied to prescription of antihypertensive medication. Positive number demonstrates improvement.
†Odds ratios obtained using mixed effects logistic regression, clustered by village and study region. For control of hypertension, the dependent variable was control of hypertension at follow-up, with adjustment for control of hypertension at baseline (ICC: overall, 0.002; women, 0.003; men, 0.008). The same approach was applied to prescription of antihypertensive medication (ICC: overall, 0.04; women, 0.02; men, 0.09).
‡A person who did not have blood pressure measured at follow-up had details of medications, and so there is an extra observation for the latter analysis.
ICC, intraclass correlation coefficient; UC, usual care.